News

Cell transplants make gains versus diabetes

By
1:06pm, February 28, 2005

Transplanting insulin-making cells from fresh cadavers into diabetes patients can reverse the disease, but the procedure has been too costly for widespread use. Scientists have now developed a less costly version of the procedure.

In a trial of cell transplants in eight patients, five were free of disease 1 year after their transplants, a success rate comparable to that of previous cell-transplant trials. However, in those earlier trials, every patient received an infusion of cells from each of two or occasionally more cadavers. Each infusion costs about $75,000, including the first year of follow-up treatment. In the new trial, the transplant cells for each patient came from only one cadaver—a cost-saving procedure that could make cell transplants more commonplace, says study coauthor Bernhard J. Hering of the University of Minnesota in Minneapolis.

This article is available only to subscribing members. Join SSP today or Log in.

More from Science News